Durable clinical benefit following Sr90 Beta irradiation therapy for in-stent restenosis in high-volume community practice. Academic Article uri icon

Overview

abstract

  • Although randomized clinical trials have demonstrated efficacy of coronary irradiation versus placebo for the treatment of in-stent restenosis (ISR), durable long-term benefit in community practice is less well defined. From January 1, 2001, through June 30, 2002, consecutive percutaneous coronary intervention (n = 3,869) were analyzed at our center with a total of 330 patients undergoing coronary irradiation for ISR (53, Ir192; 12, P32; 265 Novoste Sr90). Novoste Sr90 was successfully performed in 265 of 270 (98%) of patients attempted by 10 operators. The mean patient age was 63 years (range 35 90) with 55% male (145/265) and 45% female (120/265). ISR anatomic subsets included multi-lesion (45/265; 17%), multi-vessel (27/265; 10.0%) and saphenous vein graft (16/265; 6.0%) interventions. At a mean follow-up of 10.5 2.8 (SD) months, fifty-three (20%) of the Novoste Sr90 treated patients had returned for symptoms requiring repeat angiography. Of these, 23 patients had repeat percutaneous coronary intervention (PCI) including 2 target site revascularizations (TSR), twelve non-TSR (distinct from the radiated segment of the target vessel), and 9 non-target vessel revascularizations (TVR). Coronary artery bypass surgery was performed in 11 total patients, 4 due to TSR, and 7 due to non-TVR. Clinical TSR was 2.3% (6/265) and TVR was 6.8% (18/265). In conclusion, the Novoste SR90 Beta-Cath System for the treatment of ISR is associated with a high procedural success rate and low TSR and TVR. Revascularization in follow-up is predominantly due to progressive disease outside the radiated segment and aggressive secondary prevention, especially prolonged anti-platelet therapy, appear critical to long-term procedural success.

authors

  • Kleiman, Neal
  • Young, John J
  • Marcus, Daniel P
  • Abbottsmith, Charles W
  • Broderick, Thomas M
  • Choo, Joseph K
  • Runyon, John Paul
  • Schneider, John F
  • Shimshak, Thomas M
  • Geier, Rodney P
  • Kereiakes, Dean J

publication date

  • January 1, 2003

Research

keywords

  • Beta Particles
  • Community Health Services
  • Coronary Restenosis
  • Stents
  • Strontium Radioisotopes

Identity

Scopus Document Identifier

  • 0038175269

PubMed ID

  • 12668834

Additional Document Info

volume

  • 15 Suppl A